SCHEMBL14895460

SCHEMBL14895460

NCc1ccc([CH]CO)s1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2E1 P05181 5/20 0.38
CYP2A6 P11509 5/20 0.38
CYP3A4 P08684 4/20 0.38
CYP2C9 P11712 4/20 0.38
CYP2B6 P20813 4/20 0.38
CYP2C19 P33261 4/20 0.38
LOX P28300 13/20 0.37
LTA4H P09960 1/20 0.36
LOXL2 Q9Y4K0 5/20 0.33
CYP2D6 P10635 3/20 0.33
MAOA P21397 1/20 0.33
CYP1A2 P05177 2/20 0.33
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CYP2C8 P10632 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8191376 0.74
SCHEMBL1680891 0.73 ALDH1A1 (0.41) CYP2E1CYP2A6CYP3A4CYP2C9CYP2B6
SCHEMBL8125451 0.71 CYP2E1 (0.38) CYP2E1CYP2A6CYP3A4CYP2C9CYP2B6
SCHEMBL7357714 0.70
SCHEMBL1680558 0.68 LOX (0.36) CYP2E1CYP2A6CYP3A4CYP2C9CYP2B6
SCHEMBL1680452 0.66 LOX (0.37) CYP2E1CYP2A6CYP3A4CYP2C9CYP2B6
SCHEMBL29574366 0.64 LTA4H (0.68) CYP2E1CYP2A6CYP3A4CYP2C9CYP2B6
SCHEMBL12657211 0.62
Iodide SCHEMBL29574376 0.62 LTA4H (0.65) CYP2E1CYP2A6CYP3A4CYP2C9CYP2B6
SCHEMBL29953913 0.62 TSHR (0.48) CYP2E1CYP2A6CYP3A4CYP2C9CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2771332-B1 Thiophen and thiazol sulfonamid derivatives as HIV protease inhibitors for the treatment of AIDS MERCK CANADA INC (CA) 2016-06-29 EP disclosed
EP-2771332-A1 HIV PROTEASE INHIBITORS Merck Canada Inc. (CA) 2014-09-03 EP disclosed
WO-2013059928-A1 HIV PROTEASE INHIBITORS MERCK CANADA INC. (CA) 2013-05-02 WO disclosed